Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2006
11/15/2006CN1861062A Medicine composition used for fish or other aquatic livings and its prepn. method
11/15/2006CN1861061A Medicine for treating or preventing newborn hemorrhagic disease
11/15/2006CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
11/15/2006CN1284571C Health-care food for improving nutritional anemia
11/15/2006CN1284555C Compound fineleaf schizonepeta oil soft capsule
11/15/2006CN1284550C Chinese herbal medicine for treating aplastic anemia
11/15/2006CN1284522C Dextrose and insulin fluid formulation for intravenous infusion
11/14/2006US7135587 Such as 3-biphenyl-4-yl-3-(2-(3-(pyridin-2-ylamino)pro-poxycarbonylamino) -ethanoylamino)propionic acid; thromboses, cardiac infarction, coronary heart disease, arteriosclerosis, inflammation, tumors. osteoporosis, infections, restenosis
11/14/2006US7135474 In combination with organic nitrate or nitric oxide donors or inhibitors of cyclic GMP metabolism; erectile dysfunction or female sexual dysfunction
11/14/2006US7135471 Aryl oximes
11/14/2006US7135464 Method of administering decitabine
11/14/2006US7135196 Iron compositions
11/14/2006CA2367124C A thrombin blood fraction for use in a medical procedure
11/14/2006CA2342271C Gem substituted hydroxamic acids
11/14/2006CA2340320C Use of an angiogenic factor for the treatment of microascular angiopathies
11/09/2006WO2006119154A1 Use of pyrimidylamimobenzamide derivatives for the treatment of systematic mastocytosis
11/09/2006WO2006118350A1 Anti-platelet membrane glycoprotein vi monoclonal antibody
11/09/2006WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006WO2006117185A1 Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome
11/09/2006WO2006116948A1 Interleukin-6 polyethylene glycol conjugate and its preparing method and use
11/09/2006WO2006116905A1 Medicinal compounds as antagonists of the platelet- activating factor receptor
11/09/2006WO2006116899A1 The system, solid phase medium, device and method for bio-fluid treatment
11/09/2006US20060252810 e.g. 5-(4-Fluorophenyl)-4-(4-pyridinyl)imidazole-2-thio-3-propyl-N-phthalimide; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
11/09/2006US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands
11/09/2006US20060252792 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
11/09/2006US20060252730 Adenosine receptor antagonists and methods of making and using the same
11/09/2006US20060252690 Factor VII or VIIa - Like Molecules
11/09/2006US20060252689 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/09/2006US20060252127 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/09/2006US20060251713 Amino acid sequences capable of facilitating penetration across a biological barrier
11/09/2006US20060251655 Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same
11/09/2006US20060251578 Therapeutic and diagnostic compounds, compositions, and methods
11/09/2006CA2606716A1 Use of pyrimidylaminobenzamide derivatives for the treatment of systematic mastocytosis
11/09/2006CA2606450A1 Anti-platelet membrane glycoprotein vi monoclonal antibody
11/09/2006CA2606068A1 Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome
11/08/2006EP1719757A1 Bicyclo derivative
11/08/2006EP1719526A2 Pharmaceutical combinations comprising a P2T receptor antagonist and another anti-thrombotic agent
11/08/2006EP1719517A1 Artificial physiological salt solution and process for producing the same
11/08/2006EP1361882B1 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
11/08/2006EP1337269B1 Association of calpain inhibitors and reactive oxygen species trapping agents
11/08/2006EP1294691B1 Serine protease inhibitors
11/08/2006CN1860239A Method of preparing alpha-glycosylisoquercitrin, intermediate therefor and by-product
11/08/2006CN1860097A Amide type carboxamide derivative
11/08/2006CN1859921A Method of processing ginseng for medicinal use and composition
11/08/2006CN1859913A Method of improved diuresis in individuals with impaired renal function
11/08/2006CN1857722A Use of cereour bacillus in preparing thrombus treating medicine
11/08/2006CN1857721A Pyridoxal phosphate internally cross-linked hematoglobin nanocapsule and its preparing method
11/08/2006CN1857676A Zedoary oil microcapsule preparation and its preparing process
11/08/2006CN1857629A Hematuria treating Chinese medicine and its preparing method and use
11/08/2006CN1857627A Apoplexy treating Chinese medicine preparation and its preparing process
11/08/2006CN1857624A Thrombus treating Chinese medicine
11/08/2006CN1857617A No-sugar Mailuoning granule and its preparing process and quality control method
11/08/2006CN1857612A Method for preparing Chinese medicine composition for treating cerebral thrombus and its prepared Chinese medicine composition
11/08/2006CN1857567A Preparing method of coated Tongshu tablet
11/08/2006CN1857555A Infantile blood generation promoting granule and its preparing method
11/08/2006CN1857534A Medicine composition for treating cardiac and cerebral vascular diseases
11/08/2006CN1857533A Chinese medicine preparation for preventing and treating cerebral thrombus and its sequel
11/08/2006CN1857521A Preparing process and product of Chinese medicine dripping pill with tea extract
11/08/2006CN1857473A Gynostemma pentaphylla saponin composition preparation and its preparing process
11/08/2006CN1857471A Tribuloside composition preparing and its preparing process
11/08/2006CN1857470A Preparation and application of shortscape fleabane herb flavonid composition
11/08/2006CN1857469A Arasaponin composition preparation and its preparing process
11/08/2006CN1857468A Prepn and application of haw heaf total phenolic acid composition
11/08/2006CN1857441A Preparation and application of total salvianolic acid composition
11/08/2006CN1857440A Preparation and application of total paeoniflorin composition
11/08/2006CN1857439A Preparation and application of ginkgo leaf flavonid composition
11/08/2006CN1857395A Compound Chinese medicine composition for treating cardiac and cerebral vascular diseases
11/08/2006CN1857392A Disperser tablet for cooling blood and relieving pain and its preparing method and use
11/08/2006CN1857387A Preparation and application of pueraria flavonid composition
11/08/2006CN1857377A Preparation and application of total safflower flavone composition
11/08/2006CN1857370A Notoginseng hemostatic and its preparing method
11/08/2006CN1857356A Preparation and application of total seabuckthorn flavone composition
11/08/2006CN1857348A Water soluble Chinese angelica extract and its injection and their preparing process
11/08/2006CN1857344A New use and preparation of smoke tree extract for Chinese medicine
11/08/2006CN1857311A Blood replacing base liquid for blood purification treatment
11/08/2006CN1857299A New use of mankshood polysaccharide in preventing and treating post-chemotherapy bone marrow arrest
11/08/2006CN1857292A Thrombus eliminating soft capsule and its preparing method
11/08/2006CN1857272A Alprostadil infusion solution and its preparing method
11/08/2006CN1283793C Chemokine-like factor superfamily having skeletal muscle stimulating activity and immunoregulation function
11/08/2006CN1283664C Erythropoietin conjugate
11/08/2006CN1283656C C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
11/08/2006CN1283641C Pteridine derivatives with nitric oxide synthase inhibitor function
11/08/2006CN1283638C Indole-2-formamide compounds as factor Xa inhibitors
11/08/2006CN1283626C Substituted benzene derivatives or salts thereof
11/08/2006CN1283610C Ketone compounds and compositions for cholesterol management and related uses
11/08/2006CN1283317C Use of opioid kappa receptor-excited compound in preparing pharmaceuticals for treating septicemia
11/07/2006US7132521 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/07/2006US7132457 Adamantane derivatives
11/07/2006US7132430 Treatment of cardiovascular and related pathologies
11/07/2006US7132429 Sulfonamido ether substituted imidazoquinolines
11/07/2006US7132416 Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia
11/07/2006US7132408 Composition and method for inhibiting platelet aggregation
11/07/2006US7132264 nucleic acid molecule comprising nucleotide sequences, that code fro single chain proteins which are serine protease inhibitors, used for prophylaxis of emphysema, cirrhosis, hepatitis, blood disorders, tumors and tumor metastasis
11/07/2006US7132118 Superoxide dismutase-containing cucumber extract coated and/or microencapsulated in a fat-soluble agent based on a fatty substance can be used by the topical or oral route; antiallergens; sunscreen agents; foods; drugs; cosmetics
11/07/2006CA2274093C Substituted pyrimidinone and pyridinone compounds and their use
11/07/2006CA2191664C Formulation for iron chelation, a process for preparing the formulation and a method of treating thalassemia
11/07/2006CA2139353C Pharmaceutical composition containing il-6, their uses for the treatment of consumptive thrombo-hemorrhagic disorder
11/02/2006WO2006116524A1 Compositions and methods for promoting hemostasis and other physiological activities
11/02/2006WO2006115652A1 Fluorinated pyridine n-oxide thrombin modulators and process for n-oxidation of nitrogen containing heteroaryls
11/02/2006WO2006115274A1 Myeloerythroid progenitor differentiation inducer